Overview of This Study:

The study involved four major activities in estimating the current size of the cardiac mapping market. Exhaustive secondary research was done to collect information on the market and its different subsegments.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary…

Research Methodologies Followed for This Study:

Secondary Research:

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this…

Overview of This Study:

This study involved four major activities in estimating the size of the Care Management Solutions Market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through…

Major Objectives Behind This Study:

# To define, describe, and forecast the Clinical Trial Management System Market based on product & service, deployment mode, deployment type, and end user.

# To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and…

Overview:

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global drug discovery services market.

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs),…

Drug delivery technologies improve the efficacy and safety of a drug by controlling the rate, time, and place of drug release in the body. This market is highly competitive and is witnessing rapid growth due to the development of numerous new routes of drug delivery. The global pharmaceutical industry is research-intensive, with innovative firms spending on average about 15% of their sales on R&D. Also, the increasing R&D expenditure on early-stage development, as well as an increase…

Recent Developments in the Global Apheresis Market:

# In July 2019, Baxter International Inc. (US) launched the PrisMax system in the US.

# In June 2019, Toray Medical Co. Ltd. (Japan) launched the TORAMYXIN device in the European region.

# In October 2019, Terumo BCT (US) collaborated with the UniCAR-Therapy Bio-Medicine Technology Co. (China). This collaboration…

Active Pharmaceutical Ingredient MarketDynamics:

DRIVER: Adoption of organ on chip models in drug development

Despite massive investments in pharma R&D, there has been a direct decrease in the annual number of new FDA-approved drugs—almost directly proportional to the increase in R&D spending. To curb the high cost of drug development, there is a growing need to develop…

Major Growth Boosting Factors:

Market growth is largely driven by the increasing R&D expenditure in pharmaceutical and biopharmaceutical companies and the growing number of clinical trials conducted globally. However, the increasing cost of drug development and clinical trials is expected to restrain the growth of this market during the forecast period.

Expected Revenue Gains:

The global clinical trial supplies market is projected to reach USD 2.9 billion by 2026…

Major Growth Boosting Factors:

Increasing R&D investments in the pharmaceutical and biotechnology industry is driving the growth of the market. Moreover, growth opportunities in emerging countries as well as the emergence of green chemistry,is likely to provide opportunities for the chiral chromatography column industry.

Expected Revenue Gains:

The chiral chromatography column market size is projected to reach USD 123 million by 2025 from an estimated USD 99 million…

Market Size Estimation:

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by product, application, end user, and region).

Data Triangulation:

After arriving at the market size, the total…

Vital Factors Boosting Global Industry Growth:

Increasing prevalence of transplantation, technological advancements and increased funding and public-private investments are the key factors driving the growth of the human organoids market.

Expected Revenue Gains:

The global human organoids market size is estimated to be USD 850 million in 2020 and…

Overview:

This study involved four major activities in estimating the current size of the active pharmaceutical ingredient market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through…

Neuroprostheses uses electrodes to interface with the central or peripheral nervous system to restore lost motor or sensory capabilities. These devices can receive neural signals from the external environment & brain, and convert the signals to restore functions such as loss of hearing and vision. They have applications in cognitive disorders, ophthalmic disorders, motor disorders, and auditory disorders.

Expected Revenue Gains:

The neuroprosthetics market is projected to…

Objectives of the Study:

# To define, describe, and forecast the protein binding assay market on the basis of technology, end user, and regions.

# To provide detailed information about factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges).

# To strategically analyze the micromarkets with respect to…

Major Growth Drivers:

The growing need to reduce operational costs (while increasing the operational efficiency of healthcare organizations) and the growing need to maintain compliance with regulatory mandates are key drivers of Healthcare Contract Management Software Market. On the other hand, the dearth of in-house IT expertise and the…

Overview of This Study:

This study involved four major activities in estimating the current size of the neurovascular devices market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and market sizing with industry experts across…

Global Leading Companies:

Key players in healthcare contract management software market include Determine Inc. (US), CobbleStone Software (US), Concord (US), Contract Logix LLC (US), Icertis (US), Apttus Corporation (US), Optum Inc. (US), nThrive Inc. (US), Experian Plc. (Ireland), Coupa Software Inc. (US), and ScienceSoft (US).

Expected…

Major Growth Boosting Factors:

Factors such as the growing public awareness about the therapeutic potential of stem cells; development of novel technologies for stem cell preservation, processing & storage; rising number of hematopoietic stem cell transplantations (HSCTs); and increasing investments in stem cell-based research are driving the growth of the market. However, the high operational costs associated with stem cell banking and stringent regulatory frameworks are expected…

Growth Boosting Factors:

The stringent safety and quality regulations governing product certification and testing across the biopharmaceutical and pharmaceutical industries, high demand for the outsourcing of bioprocess validation services and rising R&D spending in the life science are some of the major factors that are expected to drive the growth of bioprocess validation market during the forecast period. Additionally, automation in bioprocess validation services and geographic…